Open Emergency Modal
Yashoda Medicity has enhanced its computed tomography (CT) capabilities with the GE Revolution Frontier, a 256-slice dual-energy spectral CT system utilizing artificial intelligence (AI) technology to advance imaging diagnostics. In conjunction with high-speed volumetric scanning capabilities, this advanced system enhances diagnostic accuracy through sophisticated spectral imaging techniques for complex medical evaluations. The integration of AI into the reconstruction pipeline improves image clarity, reduces imaging artefacts, and enhances workflow efficiency within the radiology department.
A major strength of the GE Revolution Frontier is its ability to simultaneously acquire dual-energy datasets using high-speed kilovolt switching technology. This provides advanced material decomposition capabilities, enabling clinicians to quantify iodine uptake, characterise tissue composition, and obtain additional diagnostic information beyond conventional CT imaging.
Additionally, Dr. Gagan Saini and the radiology team are able to characterise tissues through advanced material decomposition, aiding in the differentiation of benign and malignant lesions with greater diagnostic confidence. These capabilities are particularly valuable in both oncology and cardiovascular imaging. In cardiovascular imaging, the 256-slice acquisition is capable of capturing high-quality diagnostic data in a fraction of the time, helping reduce motion-related artefacts even in patients with elevated heart rates and enabling physicians to obtain clearer information for coronary angiography and other cardiac assessments.
In oncology, the system supports precise tumour detection, accurate lesion characterisation, and preoperative planning by providing clinicians with greater confidence in distinguishing between benign and malignant tissues. In addition to its applications in oncology and cardiovascular care, the system also supports advanced imaging across neurology, vascular imaging, trauma, emergency medicine, and other clinical specialities, contributing to more informed clinical decision-making and personalised treatment planning.